首页> 外文期刊>Nucleic Acids Research >Cooperative genomic alteration network reveals molecular classification across 12 major cancer types
【24h】

Cooperative genomic alteration network reveals molecular classification across 12 major cancer types

机译:合作基因组改变网络揭示了12种主要癌症类型的分子分类

获取原文
获取原文并翻译 | 示例
           

摘要

The accumulation of somatic genomic alterations that enables cells to gradually acquire growth advantage contributes to tumor development. This has the important implication of the widespread existence of cooperative genomic alterations in the accumulation process. Here, we proposed a computational method HCOC that simultaneously consider genetic context and downstream functional effects on cancer hallmarks to uncover somatic cooperative events in human cancers. Applying our method to 12 TCGA cancer types, we totally identified 1199 cooperative events with high heterogeneity across human cancers, and then constructed a pan-cancer cooperative alteration network. These cooperative events are associated with genomic alterations of some highconfident cancer drivers, and can trigger the dysfunction of hallmark associated pathways in a codefect way rather than single alterations. We found that these cooperative events can be used to produce a prognostic classification that can provide complementary information with tissue-of-origin. In a further case study of glioblastoma, using 23 cooperative events identified, we stratified patients into molecularly relevant subtypes with a prognostic significance independent of the Glioma-CpG Island Methylator Phenotype (GCIMP). In summary, our method can be effectively used to discover cancer-driving cooperative events that can be valuable clinical markers for patient stratification.
机译:使细胞能够逐渐获得增长优势的体细胞基因组改变的积累有助于肿瘤发育。这具有对积累过程中的合作基因组改变的广泛存在的重要意义。在这里,我们提出了一种计算方法HCOC,同时考虑遗传背景和下游功能影响癌症标志,以发现人类癌症中的体细胞合作事件。将我们的方法应用于12种TCGA癌症类型,我们完全鉴定了人类癌症的1199名具有高异质性的合作症,然后构建了泛癌合作改变网络。这些合作事件与一些高档癌症司机的基因组改变有关,并且可以以CODEFECT方式触发标志相关途径的功能障碍,而不是单一的改变。我们发现这些合作事件可用于产生预后分类,可以提供具有组织组织的互补信息。在进一步研究胶质母细胞瘤的情况下,使用鉴定的23个合作事件,我们将患者分解成分子相关的亚型,其具有预后意义,与Gliooma-CpG岛甲基甲蛋白表型(GCIMP)无关。总之,我们的方法可以有效地用于发现癌症驾驶协作事件,这些事件可以是患者分层的有价值的临床标志。

著录项

  • 来源
    《Nucleic Acids Research》 |2017年第2期|共16页
  • 作者单位

    Harbin Med Univ Coll Bioinformat Sci &

    Technol Harbin 150081 Heilongjiang Peoples R China;

    Harbin Med Univ Coll Bioinformat Sci &

    Technol Harbin 150081 Heilongjiang Peoples R China;

    Harbin Med Univ Coll Bioinformat Sci &

    Technol Harbin 150081 Heilongjiang Peoples R China;

    Harbin Med Univ Coll Bioinformat Sci &

    Technol Harbin 150081 Heilongjiang Peoples R China;

    Harbin Med Univ Coll Bioinformat Sci &

    Technol Harbin 150081 Heilongjiang Peoples R China;

    Harbin Med Univ Coll Bioinformat Sci &

    Technol Harbin 150081 Heilongjiang Peoples R China;

    Harbin Med Univ Coll Bioinformat Sci &

    Technol Harbin 150081 Heilongjiang Peoples R China;

    Harbin Med Univ Coll Bioinformat Sci &

    Technol Harbin 150081 Heilongjiang Peoples R China;

    Harbin Med Univ Coll Bioinformat Sci &

    Technol Harbin 150081 Heilongjiang Peoples R China;

    Harbin Med Univ Coll Bioinformat Sci &

    Technol Harbin 150081 Heilongjiang Peoples R China;

    Harbin Med Univ Coll Bioinformat Sci &

    Technol Harbin 150081 Heilongjiang Peoples R China;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 生物化学;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号